Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-01-25 @ 4:05 AM
Study NCT ID:
NCT00343733
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2006-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Sponsor:
Cephalon
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C25608/3052/BP/US
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None